CY1109140T1 - Τυποποιησεις εμβολιων που περιλαμβανουν αντιιδιοτυπικα αντισωματα τα οποια μιμουνται ανοσολογικα υαδατανθρακες των στρεπτοκοκκων ομαδας β - Google Patents
Τυποποιησεις εμβολιων που περιλαμβανουν αντιιδιοτυπικα αντισωματα τα οποια μιμουνται ανοσολογικα υαδατανθρακες των στρεπτοκοκκων ομαδας βInfo
- Publication number
- CY1109140T1 CY1109140T1 CY20091100604T CY091100604T CY1109140T1 CY 1109140 T1 CY1109140 T1 CY 1109140T1 CY 20091100604 T CY20091100604 T CY 20091100604T CY 091100604 T CY091100604 T CY 091100604T CY 1109140 T1 CY1109140 T1 CY 1109140T1
- Authority
- CY
- Cyprus
- Prior art keywords
- outcomes
- immunological
- carbons
- street
- immune
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000001900 immune effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 1
- 241000194017 Streptococcus Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4233—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-bacterial Ig
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808327.2A GB9808327D0 (en) | 1998-04-20 | 1998-04-20 | Antidiotypic compounds |
| EP99914725A EP1071763B1 (en) | 1998-04-20 | 1999-04-20 | Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109140T1 true CY1109140T1 (el) | 2014-07-02 |
Family
ID=10830608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100604T CY1109140T1 (el) | 1998-04-20 | 2009-06-09 | Τυποποιησεις εμβολιων που περιλαμβανουν αντιιδιοτυπικα αντισωματα τα οποια μιμουνται ανοσολογικα υαδατανθρακες των στρεπτοκοκκων ομαδας β |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6676938B1 (enExample) |
| EP (1) | EP1071763B1 (enExample) |
| JP (2) | JP4446601B2 (enExample) |
| AT (1) | ATE425251T1 (enExample) |
| CA (1) | CA2325566C (enExample) |
| CY (1) | CY1109140T1 (enExample) |
| DE (1) | DE69940545D1 (enExample) |
| GB (1) | GB9808327D0 (enExample) |
| WO (1) | WO1999054457A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10027695A1 (de) * | 1999-05-27 | 2001-04-19 | Max Delbrueck Centrum | Vakzine gegen konformationsabhängige Antigene sowie gegen Antigene, die keine oder nicht ausschließlich Proteine oder Peptide sind |
| AU1412702A (en) | 2000-10-27 | 2002-05-06 | Chiron Spa | Nucleic acids and proteins from streptococcus groups a and b |
| AU2003260102A1 (en) * | 2002-08-26 | 2004-03-11 | Chiron Corporation | Conserved and specific streptococcal genomes |
| PT1648500E (pt) | 2003-07-31 | 2014-10-10 | Novartis Vaccines & Diagnostic | Composições imunogénicas para estreptococos piogenes |
| US8945589B2 (en) | 2003-09-15 | 2015-02-03 | Novartis Vaccines And Diagnostics, Srl | Immunogenic compositions for Streptococcus agalactiae |
| EP1784211A4 (en) | 2004-07-29 | 2010-06-30 | Novartis Vaccines & Diagnostic | IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE |
| JP2008544949A (ja) * | 2004-10-08 | 2008-12-11 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 化膿性レンサ球菌のための免疫激性組成物および治療用組成物 |
| WO2006069200A2 (en) * | 2004-12-22 | 2006-06-29 | Novartis Vaccines And Diagnostics Inc. | Group b streptococcus |
| NZ599345A (en) | 2005-02-18 | 2013-07-26 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic Escherichia Coli |
| ATE522541T1 (de) * | 2006-06-09 | 2011-09-15 | Novartis Ag | Bakterielle adhäsine konformere |
| JP2010500399A (ja) | 2006-08-16 | 2010-01-07 | ノバルティス アーゲー | 尿路病原性大腸菌由来の免疫原 |
| AU2007348285A1 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| MX2010002773A (es) | 2007-09-12 | 2010-03-31 | Novartis Ag | Antigenos mutantes de gas57 y anticuerpos de gas57. |
| CA2709927C (en) | 2007-12-21 | 2017-05-16 | Novartis Ag | Mutant forms of streptolysin o |
| US8822663B2 (en) | 2010-08-06 | 2014-09-02 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| CA2821992A1 (en) | 2010-10-01 | 2012-04-05 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| DE12722942T1 (de) | 2011-03-31 | 2021-09-30 | Modernatx, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| HRP20220250T1 (hr) | 2011-10-03 | 2022-04-29 | Modernatx, Inc. | Modificirani nukleozidi, nukleotidi i nukleinske kiseline, te njihove uporabe |
| SI2791160T1 (sl) | 2011-12-16 | 2022-07-29 | Modernatx, Inc. | Sestave modificirane MRNA |
| US10501512B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides |
| AU2013243952A1 (en) | 2012-04-02 | 2014-10-30 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| SMT202200337T1 (it) | 2012-11-26 | 2022-09-14 | Modernatx Inc | Rna modificato al livello del terminale |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
| US10323076B2 (en) | 2013-10-03 | 2019-06-18 | Modernatx, Inc. | Polynucleotides encoding low density lipoprotein receptor |
| EP3773348B1 (en) | 2018-04-10 | 2025-04-02 | Alps Holding Llc | Spinal interbody cage comprising top and bottom faces with mesh structures, pillars and slots |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5476784A (en) * | 1993-04-06 | 1995-12-19 | Rice; Peter A. | Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| ATE332372T1 (de) * | 1996-05-29 | 2006-07-15 | Derek Nigel John Hart | Rezeptor von dendritischen zellen. |
| US6140091A (en) * | 1997-06-20 | 2000-10-31 | Boston Biomedical Research Institute | Anti-idiotype vaccines to elicit catalytic antibodies |
| US6444787B1 (en) * | 1997-12-31 | 2002-09-03 | Research Development Institute, Inc. | Method of isolating a peptide which immunologically mimics microbial carbohydrates including group B streptococcal carbohydrates and the use thereof in a vaccine |
-
1998
- 1998-04-20 GB GBGB9808327.2A patent/GB9808327D0/en not_active Ceased
-
1999
- 1999-04-20 WO PCT/IB1999/000799 patent/WO1999054457A1/en not_active Ceased
- 1999-04-20 AT AT99914725T patent/ATE425251T1/de active
- 1999-04-20 CA CA2325566A patent/CA2325566C/en not_active Expired - Fee Related
- 1999-04-20 EP EP99914725A patent/EP1071763B1/en not_active Expired - Lifetime
- 1999-04-20 US US09/673,867 patent/US6676938B1/en not_active Expired - Fee Related
- 1999-04-20 DE DE69940545T patent/DE69940545D1/de not_active Expired - Lifetime
- 1999-04-20 JP JP2000544789A patent/JP4446601B2/ja not_active Expired - Fee Related
-
2003
- 2003-11-07 US US10/703,886 patent/US6900302B2/en not_active Expired - Fee Related
-
2009
- 2009-05-21 JP JP2009123637A patent/JP2009179645A/ja not_active Withdrawn
- 2009-06-09 CY CY20091100604T patent/CY1109140T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2325566C (en) | 2011-02-08 |
| EP1071763A1 (en) | 2001-01-31 |
| DE69940545D1 (de) | 2009-04-23 |
| CA2325566A1 (en) | 1999-10-28 |
| US6676938B1 (en) | 2004-01-13 |
| US6900302B2 (en) | 2005-05-31 |
| GB9808327D0 (en) | 1998-06-17 |
| JP2002512026A (ja) | 2002-04-23 |
| WO1999054457A1 (en) | 1999-10-28 |
| ATE425251T1 (de) | 2009-03-15 |
| EP1071763B1 (en) | 2009-03-11 |
| JP2009179645A (ja) | 2009-08-13 |
| JP4446601B2 (ja) | 2010-04-07 |
| US20040101536A1 (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109140T1 (el) | Τυποποιησεις εμβολιων που περιλαμβανουν αντιιδιοτυπικα αντισωματα τα οποια μιμουνται ανοσολογικα υαδατανθρακες των στρεπτοκοκκων ομαδας β | |
| CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| CY1119650T1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| DK1093381T3 (da) | Antigene peptider afledt fra teleromerase | |
| CY1108083T1 (el) | Αντιγονα και συνθεσεις του neisseria meningitidis | |
| WO2005058937A3 (en) | A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 | |
| DK1584685T3 (da) | Tumorassocieret antigenderivater fra Mage-familien, anvendt til fremstilling af fusionsproteiner med T-hjælper epitoper og sammensætninger til vaccination | |
| DK53687A (da) | Peptid_fra htlv-iii-viruskappeprotein | |
| ATE542829T1 (de) | Impfstoff | |
| CY1115842T1 (el) | Συμπληρωμενο ομv εμβολιο κατα μηνιγγιtiδοκοκκου | |
| CY1114722T1 (el) | Αντιγονα στρεπτοκοκκου | |
| CY1116506T1 (el) | Αντισωματα εναντι masp-2 | |
| CY1106532T1 (el) | Ετερολογος εκφραση των πρωτεϊνων της neisseria | |
| CY1114333T1 (el) | Αντιγονα του neisseria meningitidis | |
| CO5050400A1 (es) | Proteina de chlamydia, secuencia de genes y anticuerpos para ello | |
| ES2165851T3 (es) | Proteinas multivalentes que se unen a antigenos. | |
| DE69111801D1 (de) | Vakzin gegen hepatitis b. | |
| CY1111286T1 (el) | Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα | |
| ATE370745T1 (de) | Verbesserte polysaccharid- und glykokonjugat- vakzine | |
| CY1107322T1 (el) | Συνδυασμενο εμβολιο κατα της hπατιτιδας α και ηπατιτιδας β | |
| NO20004412L (no) | HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisningav antistoffer fremkalt av HIV | |
| DE69922212D1 (de) | Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp) | |
| NO20042854L (no) | Vaksiner og antistoff produsert fra virus utledet fra en udodelig cellelinje fra grouper epinephelus coioides | |
| DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| FI943418A7 (fi) | Synteettiset peptidit vihurirokkorokotetta varten |